Cleared Traditional

K113744 - QUILL PDO KNOTLESS TISSUE-CLOSURE DEVICE (POLYDIOXANONE)

K113744 is an FDA 510(k) clearance for QUILL PDO KNOTLESS TISSUE-CLOSURE DEVIC..., manufactured by Angiotech. The device is a Class 2 General & Plastic Surgery device with product code NEW cleared through the Traditional 510(k) pathway after a 43-day FDA review.

K113744 · Angiotech · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2012
Decision
43d
Days
Class 2
Risk

K113744 is an FDA 510(k) clearance for the QUILL PDO KNOTLESS TISSUE-CLOSURE DEVICE (POLYDIOXANONE). Classified as Suture, Surgical, Absorbable, Polydioxanone (product code NEW), Class II - Special Controls.

Submitted by Angiotech (Reading, US). The FDA issued a Cleared decision on February 1, 2012 after a review of 43 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4840 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Angiotech devices

FDA 510(k) Submission Details - K113744

510(k) Number K113744 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2011
Decision Date February 01, 2012
Days to Decision 43 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 115d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NEW Device Classification - Class 2, Special Controls

Product Code NEW Suture, Surgical, Absorbable, Polydioxanone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - NEW Suture, Surgical, Absorbable, Polydioxanone

All 54
Devices cleared under the same product code (NEW) and FDA review panel - the closest regulatory comparables to K113744.
QUILL PDO KNOTLESS TISSUE-CLOSURE DEVICE, VARIABLE LOOP DESIGN
K123877 · Surgical Specialties Corp. Dba Angiotech · Jan 2013
QUILL PDO KNOTLESS TISSUE-CLOSURE DEVICE (POLYDIXANONE)
K120827 · Angiotech · Jul 2012
DIGITEX SUTURE DELIVERY SYSTEM, DIGITEXPOLYPROPYLENE SUTURE CARTRIDGE SIZE 0, WITH NEEDLE AND WITHOUT NEEDLE, DIGITEX
K120284 · Coloplast A/S · May 2012
PDS(TM) BARBED SUTURES
K113004 · Ethicon, Inc. · Dec 2011
PDM, VILET, VILET QUICK, MONO Q, PLAIN GUT:# 6 CHROMIC GUT
K100461 · Riverpoint Medical · Jul 2010
QUILL SELF-RETAINING SYSTEM (SRS) COMPRISED OF POLYDIOXANONE (PDO)
K080985 · Surgical Specialties Corp · Apr 2008